These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38278591)

  • 1. Preoperative Patient Evaluation: Newer Hypoglycemic Agents.
    Villasenor M; Selzer AR
    Anesthesiol Clin; 2024 Mar; 42(1):41-52. PubMed ID: 38278591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
    Bolen S; Feldman L; Vassy J; Wilson L; Yeh HC; Marinopoulos S; Wiley C; Selvin E; Wilson R; Bass EB; Brancati FL
    Ann Intern Med; 2007 Sep; 147(6):386-99. PubMed ID: 17638715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent and emerging therapeutic medications in type 2 diabetes mellitus: incretin-based, Pramlintide, Colesevelam, SGLT2 Inhibitors, Tagatose, Succinobucol.
    Lo MC; Lansang MC
    Am J Ther; 2013; 20(6):638-53. PubMed ID: 20838206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on cardiovascular effects of newer hypoglycaemic medications.
    Cutshall BT; Twilla JD; Olinger AS; Oliphant CS
    Ann Med; 2017 Nov; 49(7):603-612. PubMed ID: 28540743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020.
    Rhee EJ; Kim MK; Lee WY
    Endocrinol Metab (Seoul); 2021 Feb; 36(1):41-50. PubMed ID: 33677925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications.
    Eleftheriadou I; Grigoropoulou P; Liberopoulos E; Liatis S; Kokkinos A; Tentolouris N
    Curr Med Chem; 2018; 25(13):1549-1566. PubMed ID: 28554326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
    Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hypoglycemic agents and the pregnant diabetic: "from bench to bedside".
    Langer O
    Semin Perinatol; 2002 Jun; 26(3):215-24. PubMed ID: 12099312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of current and emerging therapies in type 2 diabetes mellitus.
    Mazzola N
    Am J Manag Care; 2012 Jan; 18(1 Suppl):S17-26. PubMed ID: 22559854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of type 2 diabetes: oral medications.
    Tran L; Zielinski A; Roach AH; Jende JA; Householder AM; Cole EE; Atway SA; Amornyard M; Accursi ML; Shieh SW; Thompson EE
    Ann Pharmacother; 2015 May; 49(5):540-56. PubMed ID: 25667196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic options for the management of diabetes.
    Sicat BL; Morgan LA
    Consult Pharm; 2007 Jan; 22(1):45-56. PubMed ID: 17367252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diabetes: Crossing to the other side.
    Skliros NP; Vlachopoulos C; Tousoulis D
    Hellenic J Cardiol; 2016; 57(5):304-310. PubMed ID: 27687958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of type 2 diabetes: injectable medications.
    Tran L; Zielinski A; Roach AH; Jende JA; Householder AM; Cole EE; Atway SA; Amornyard M; Accursi ML; Shieh SW; Thompson EE
    Ann Pharmacother; 2015 Jun; 49(6):700-14. PubMed ID: 25802244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hypoglycemic agents in pregnancy.
    Tran ND; Hunter SK; Yankowitz J
    Obstet Gynecol Surv; 2004 Jun; 59(6):456-63; quiz 485. PubMed ID: 15167767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus.
    Weidman-Evans E; Metz SM; Evans JD
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):225-33. PubMed ID: 24490745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitus.
    Joffe HV; Parks MH; Temple R
    Rev Endocr Metab Disord; 2010 Mar; 11(1):21-30. PubMed ID: 20195772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 Diabetes Medication Review.
    Sterrett JJ; Bragg S; Weart CW
    Am J Med Sci; 2016 Apr; 351(4):342-55. PubMed ID: 27079339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever.
    Basile JN
    Hosp Pract (1995); 2016; 44(1):9-20. PubMed ID: 26781810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.